Pages home > Medical cannabis - The controversy Rages On

Medical cannabis - The controversy Rages On

medical marijuana recommendation


Marijuana can also be known as pot, grass and weed nonetheless its formal name is definitely cannabis. It appears in the leaves and flowers from the plant Cannabis sativa. It really is considered an unlawful substance in america and a lot of countries and possessing marijuana is a crime punishable by law. The FDA classifies marijuana as Schedule I, substances that have an extremely high possibility of abuse and still have no proven medical use. Over the years several studies declare that some substances seen in marijuana have medicinal use, especially in terminal diseases for example cancer and AIDS. This started a fierce debate within the advantages and disadvantages from the use of medical marijuana. To settle this debate, the Institute of Medicine published the famous 1999 IOM report entitled Marijuana and Medicine: Assessing the Science Base. The report was comprehensive but did not give a clear cut pros and cons answer. The opposite camps with the medical marijuana issue often cite part of the report in their advocacy arguments. However, although the report clarified many things, it never settled the controversy completely.

Consider the issues that support why medical marijuana needs to be legalized.

(1) Marijuana is often a naturally sourced herb and has been used from South usa to Asia just as one herbal medicine for millennia. On this era in the event the natural and organic are very important health buzzwords, a naturally sourced herb like marijuana might be more popular with and safer for consumers than synthetic drugs.

(2) Marijuana has strong therapeutic potential. Several studies, as summarized within the IOM report, have seen that cannabis can be used analgesic, e.g. to treat pain. Several studies indicated that THC, a marijuana component works well for chronic pain seen by cancer patients. However, studies on acute pain including those experienced during surgery and trauma have inconclusive reports. A couple of studies, also summarized within the IOM report, have established that some marijuana components have antiemetic properties and are, therefore, effective against nausea and vomiting, which are common unwanted effects of cancer chemotherapy and radiotherapy. Some researchers think that cannabis has some therapeutic potential against neurological diseases for example ms. Specific compounds extracted from marijuana have strong therapeutic potential. Cannobidiol (CBD), an important component of marijuana, may have antipsychotic, anticancer and antioxidant properties. Other cannabinoids have shown to prevent high intraocular pressure (IOP), a serious risk factor for glaucoma. Drugs that includes substances present in marijuana but have already been synthetically stated in the laboratory happen to be licensed by the US FDA. To illustrate Marinol, an antiemetic agent indicated for vomiting and nausea related to cancer chemotherapy. Its active component is dronabinol, an artificial delta-9- tetrahydrocannabinol (THC).

(3) One of the main proponents of medical marijuana could be the Marijuana Policy Project (MPP), a US-based organization. Many medical expert societies and organizations have expressed their support. As an example, The American College of Physicians, recommended a re-evaluation from the Schedule I classification of marijuana inside their 2008 position paper. ACP also expresses its strong support for research into the therapeutic role of marijuana along with exemption from federal prosecution; civil liability; or professional sanctioning for physicians who prescribe or dispense medical cannabis in accordance with state guidelines. Similarly, protection from criminal or civil penalties for patients who use medical cannabis as permitted under state laws.

(4) Medicinal marijuana is legally utilized in many developed countries The argument of whether they can take action, you will want to us? is the one other strong point. Some countries, including Canada, Belgium, Austria, the low countries, the uk, Spain, Israel, and Finland have legalized the therapeutic use of marijuana under strict prescription control. Some states in america may also be allowing exemptions.

Now listed here are the arguments against medical marijuana.

(1) Insufficient data on safety and efficacy. Drug regulation will depend on safety first. The security of marijuana and it is components still has to first be established. Efficacy only comes second. Even though marijuana has some beneficial health effects, the huge benefits should outweigh the hazards to be considered for medical use. Unless marijuana is known as better (safer plus more effective) than drugs currently available in the market, its approval for medical use may be a long shot. Based on the testimony of Robert J. Meyer of the Department of Health insurance and Human Services accessing a medicine or medical therapy, lacking the knowledge of using it or even if it's effective, will not benefit anyone. Simply having access, without having safety, efficacy, and adequate use information will not help patients.

(2) Unknown chemical components. Medicinal marijuana could only be easily accessible and cost-effective in herbal form. Like other herbs, marijuana falls beneath the group of botanical products. Unpurified botanical products, however, face many problems including lot-to-lot consistency, dosage determination, potency, shelf-life, and toxicity. Based on the IOM report if you have any future of marijuana like a medicine, it is in its isolated components, the cannabinoids as well as their synthetic derivatives. To fully characterize the several pieces of marijuana would cost so much time and expense that this costs from the medications that may emerge from it could be too high. Currently, no pharmaceutical company seems enthusiastic about investing money to isolate more therapeutic aspects of marijuana beyond what exactly is already you can find.

(3) Possibility of abuse. Marijuana or cannabis is addictive. It may not be as addictive as hard drugs like cocaine; nevertheless it is not denied that you've a potential for drug use linked to marijuana. It is been demonstrated by a few studies as summarized in the IOM report.

(4) Deficiency of a safe and secure delivery system. The most frequent form of delivery of marijuana is by smoking. Taking into consideration the current trends in anti-smoking legislations, this manner of delivery will not be approved by health authorities. Reliable and safe delivery systems as vaporizers, nebulizers, or inhalers continue to be at the testing stage.

(5) Symptom alleviation, not cure. Even when marijuana has therapeutic effects, it is just addressing the symptoms of certain diseases. It doesn't treat or cure these illnesses. Given that it is effective against these symptoms, finances medications available which work just as well as well as, devoid of the unwanted effects and risk of abuse related to marijuana.

The 1999 IOM report couldn't settle the debate about medical cannabis with scientific evidence offered at that time. The report definitely discouraged the application of smoked marijuana but gave a nod towards marijuana use by having a medical inhaler or vaporizer. In addition, the report also recommended the compassionate utilization of marijuana under strict medical supervision. Furthermore, it urged more funding from the research with the safety and efficacy of cannabinoids.

Precisely what stands with respect to clarifying the questions raised by the IOM report? The health authorities tend not to are most often interested in having another review. There is limited data available and whatever can be acquired is biased towards issues of safety for the side effects of smoked marijuana. Data entirely on efficacy mainly are derived from studies on synthetic cannabinoids (e.g. THC). This disparity in data bakes an objective risk-benefit assessment difficult.

Clinical studies on marijuana are few and hard to conduct on account of limited funding and strict regulations. Because of the complicated legalities involved, not many pharmaceutical publication rack investing in cannabinoid research. On many occasions, it's not at all clear the way to define medicinal marijuana as advocated and opposed by a lot of groups. Should it only make reference to the application of the botanical product marijuana or does it include synthetic cannabinoid components (e.g. THC and derivatives) too? Synthetic cannabinoids (e.g. Marinol) you can purchase are incredibly expensive, pushing people for the cheaper cannabinoid as marijuana. Naturally, the thing is further clouded by conspiracy theories regarding the pharmaceutical industry and drug regulators.

cannabis card

Last updated 967 days ago by marijuanacard84